Literature DB >> 9096243

Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.

A Misicka1, A W Lipkowski, R Horvath, P Davis, F Porreca, H I Yamamura, V J Hruby.   

Abstract

New analogues of biphalin [(Tyr-D-Ala-Gly-Phe-NH-)2] with modifications of amino acid residues in positions 3,3' and 4,4' have been synthesized. The potency and selectivity of these analogues were evaluated by competitive radioreceptor binding assay in the rat brain using [3H]CTOP (mu ligand) and [3H][p-Cl-Phe4]DPDPE (delta ligand) as ligands, and by bioassay in the mouse vas deferens (MVD, delta receptor assay) and guinea pig ileum (GPI, mu receptor assay). The symmetrical substitution of phenylalanine in positions 4 and 4' with p-fluorophenylalanine or p-nitrophenylalanine resulted in an enhancement of the affinity at both delta and mu receptors, with some increase of the selectivity for delta opioid receptors. The analogue containing p-chlorophenylalanine in positions 4 and 4' is the most selective to the delta receptors in this series, with a selectivity ratio about 5. The symmetrical substitution of the glycine-3 residue with phenylalanine resulted in a decrease of binding affinities and biological potencies at both mu & delta receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096243     DOI: 10.1016/s0024-3205(97)00069-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  New potent biphalin analogues containing p-fluoro-L-phenylalanine at the 4,4' positions and non-hydrazine linkers.

Authors:  Adriano Mollica; Francesco Pinnen; Federica Feliciani; Azzurra Stefanucci; Gino Lucente; Peg Davis; Frank Porreca; Shou-Wu Ma; Josephine Lai; Victor J Hruby
Journal:  Amino Acids       Date:  2010-10-06       Impact factor: 3.520

2.  A molecular dynamics study on opioid activities of biphalin molecule.

Authors:  Jin-Yuan Hsieh; Tzen-Yuh Chiang; Jun-Liang Chen; Yun-Wen Chen; Hong-Chang Lin; Chi-Chuan Hwang
Journal:  J Mol Model       Date:  2010-12-23       Impact factor: 1.810

Review 3.  Pharmacological traits of delta opioid receptors: pitfalls or opportunities?

Authors:  Richard M van Rijn; Julia N Defriel; Jennifer L Whistler
Journal:  Psychopharmacology (Berl)       Date:  2013-05-07       Impact factor: 4.530

Review 4.  Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

Authors:  Patrycja Redkiewicz; Jolanta Dyniewicz; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

5.  Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus.

Authors:  Jolanta Dyniewicz; Piotr F J Lipiński; Piotr Kosson; Marta Bochyńska-Czyż; Joanna Matalińska; Aleksandra Misicka
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

6.  Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP).

Authors:  Thamer H Albekairi; Bhuvaneshwar Vaidya; Ronak Patel; Saeideh Nozohouri; Heidi Villalba; Yong Zhang; Yeon Sun Lee; Abraham Al-Ahmad; Thomas J Abbruscato
Journal:  Pharmaceutics       Date:  2019-09-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.